Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
26.26 USD | -9.07% | -3.67% | -16.74% |
Mar. 28 | Materials Gain After Strong Economic Data - Materials Roundup | DJ |
Mar. 28 | Chemours falls on weak quarterly sales forecast after internal review | RE |
Financials (USD)
Sales 2024 * | 6.2B | Sales 2025 * | 6.59B | Capitalization | 3.9B |
---|---|---|---|---|---|
Net income 2024 * | 523M | Net income 2025 * | 667M | EV / Sales 2024 * | 1.13 x |
Net Debt 2024 * | 3.1B | Net Debt 2025 * | 2.78B | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
7.5
x | P/E ratio 2025 * |
4.84
x | Employees | 6,200 |
Yield 2024 * |
3.9% | Yield 2025 * |
4.11% | Free-Float | 74.48% |
Latest transcript on The Chemours Company
1 day | -9.07% | ||
1 week | -3.67% | ||
Current month | +33.50% | ||
1 month | -8.57% | ||
3 months | -18.29% | ||
6 months | -5.54% | ||
Current year | -16.74% |
Managers | Title | Age | Since |
---|---|---|---|
Denise Dignam
CEO | Chief Executive Officer | 58 | 14-12-31 |
Matthew Abbott
DFI | Director of Finance/CFO | 48 | 16-12-31 |
Brandon Ontjes
IRC | Investor Relations Contact | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Cranston
BRD | Director/Board Member | 76 | 15-06-18 |
Curtis Anastasio
BRD | Director/Board Member | 67 | 15-06-18 |
Sean Keohane
BRD | Director/Board Member | 56 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 3,414 M€ | +11.02% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 26.26 | -9.07% | 6,323,594 |
24-03-27 | 28.88 | +5.52% | 1,696,408 |
24-03-26 | 27.37 | -3.52% | 1,266,866 |
24-03-25 | 28.37 | +1.83% | 1,892,238 |
24-03-22 | 27.86 | +2.20% | 1,338,474 |
Delayed Quote Nyse, March 28, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.74% | 3.9B | |
+11.27% | 87.12B | |
+8.51% | 51.03B | |
-0.34% | 32.02B | |
+11.03% | 18.39B | |
-6.18% | 12.19B | |
+11.58% | 11.79B | |
+7.03% | 10.14B | |
-6.87% | 10.04B | |
+3.12% | 9.09B |